Abstract

Heart disease: recruitment of MEF2 activity by β-blockers wards off cardiomyocyte death.

Highlights

  • Morbidity and mortality associated with cardiovascular disease is a predominant global health problem

  • The initial cue that led to the inception of these studies was accumulating evidence in the central nervous system indicating that a primary function of MEF2 in neurons is to protect them from apoptosis.[4,5]

  • The striking connection was that the earlier work, in a skeletal muscle system, elucidated that Protein kinase A (PKA) phosphorylates the MEF2 protein complex enhancing its interaction with a co-repressor (HDAC4), inactivating MEF2 function.[7,8]

Read more

Summary

Introduction

Morbidity and mortality associated with cardiovascular disease is a predominant global health problem. Death of cardiac muscle cells (cardiomyocytes) through programmed cell death (apoptosis) is one hallmark of the progression to heart failure.[1] loss of cardiomyocytes due to myocardial infarction (MI) in patients who survive the initial insult is a major determinant of residual heart function and their longer term prognosis.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.